Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5945012 | Atherosclerosis | 2014 | 5 Pages |
Abstract
Thienopyridine-SNO (an S-nitrosothiol molecule) would have the potential to participate in all the reactions expected of native nitric oxide (NO) with added benefit that the NO “moiety” is protected, transportable and largely preserved from further reactive metabolism. All these biochemical steps are present in humans and could occur prior to enzymatic biotransformation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
R.A. Anderson, S. Bundhoo, P.E. James,